Table 3.
Outcome | Median Survival Time (95% CI) | |
---|---|---|
Time Period | 2000–2006 | 2007–2013 |
All patients | 7.5 (6.8–8.2) | 9.6 (9.1–10.2) |
≤70 | 9.3 (8.6–10.1) | 11.7 (11.0–12.5) |
>70 | 3.6 (3.2–4.1) | 4.5 (3.8–5.1) |
Age group | ||
18–40 | 17.0 (11.1–22.0) | 19.7 (13.7–25.1) |
41–50 | 11.8 (10.2–13.2) | 17.3 (14.5–19.5) |
51–60 | 9.9 (9.2–11.2) | 12.4 (11.3–13.8) |
61–70 | 6.7 (5.6–7.8) | 9.3 (8.3–9.9) |
71–80 | 4.2 (3.6–5.2) | 5.2 (4.5–5.8) |
>80 | 2.0 (1.3–2.6) | 2.3 (1.4–3.1) |
Sex and age | ||
Men | 8.1 (7.1–8.9) | 9.9 (9.2–10.8) |
≤70 | 9.8 (8.6–11.1) | 11.8 (10.9–12.7) |
>70 | 3.6 (3.1–4.3) | 4.8 (3.8–5.5) |
Women | 6.7 (5.7–7.8) | 9.2 (8.2–10.1) |
≤70 | 8.9 (7.8–9.8) | 11.7 (10.3–13.3) |
>70 | 3.7 (2.8–4.6) | 4.2 (3.3–5.2) |
The estimates are age-standardized and can be compared between the two periods. Survival time shown in months.
Data from the Finnish Cancer Registry.